Clinical trial
Study Investigating Repeat Doses Of A New Medication (GSK159797) In Asthmatic…
NCT00358488 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00358488 |
|---|---|
| Title | Study Investigating Repeat Doses Of A New Medication (GSK159797) In Asthmatic Patients |
| Official title | A Multi-enter, Randomized, Double-blind, Placebo-controlled, Four-way Incomplete Block Crossover Study to Examine Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Single and Repeat Administration of Three Inhaled Doses (10, 15, and 20 mcg) of GSK159797 |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive |
| Intervention type | Drug |
| Interventions | GSK159797 (10, 15, and 20mcg), salbutamol, salmeterol 50mcg, placebo |
| Enrollment | 54 |
| Start date | Apr 1, 2006 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Jul 31, 2006 |
| Last update posted | Oct 28, 2016 |
| Countries | Germany, Netherlands, Russia, Sweden, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: